Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (63 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026



Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Three trials simultaneously...
View:
Post by wildbird1 on Oct 10, 2022 1:30pm

Three trials simultaneously...

Nobody like dilution,but sometime you have to look at the bigger picture.

There seem to be two main reasons for this $5 million financing(2.5 x 2).

1) Giving TLT enough money to get to that +$0.50 "Tipping Point".
2) Giving TLT enough money to start the process(Good Laboratoty Practice) on two new cancer trials(GBM & NSCLC).

+$0.50 " Tipping Point".
If the SP climb over $0.50 and stay over $0.50, all the warrants that are at $0.50 and lower will be exercised, and in 2023 & 2024 TLT could have secured approximately $35 million in warrants money.
In order for the SP to stay over $0.50, TLT need a catalyst, like the FDA BTD approval, except that the FDA has a say on the timelines.
The 450 days data needed for the BTD approval will be completed by TLT in Dec 2022.
The FDA has 60 days to answer the BTD request.
The FDA could also ask for clarifications on anything related to the trial.
Just to be on the safe side, TLT need money to face these possible FDA timelines.

Starting 2 new trials.
Why would TLT start the process(GLP) on 2 new trial(GMB&NSCLC) without having first completed the bladder cancer trial?

Short answer...Amazing results.
In the Aug 29,2022 newsletter, of the 32 patients treated (including the 12 undertreated) 63% still had their bladder at 270 days(TR=CR+PR=63%).
Without the 12 undertreated patients +70% would have keep their bladder at 270 days, +70% is huge for patients that were 100% guaranteed to lose their bladder.

Note1) Conducting three trials simultaneously cost money, it would have been suicidal for TLT to wait until the last minute for financing. 

The process on these 2 new trials will go much faster for 3 reasons...
1)TLT has gained a lot's of experience with the FDA & HC bladder cancer trial process.
2) The FDA & HC already know about TLD-1433 PDC compound.
3) TLT has already multiple clinical study sites in Canada & US.

Before long a steady flow of data from 3 cancer trials(Bladder,Lung,Brain) could be pushing the SP forward, at that moment we will be delighted TLT did that small $5 million financing.

Note 2) After 22 Aug, 2024(last $0.35 warrants), TLT could have approximately +300 million shares, 300 million is a puny little number for 3 cancer treatment that could be approved by the FDA.

To conclude..
I am not a big fan of peoples on this board who are predicting a very huge Shares Price for TLT in the future, but with the potential of having 3 cancer treatments approved by the FDA, maybe these over-optimistic peoples are on to something.

Time will tell.
Comment by ScienceFirst on Oct 10, 2022 2:07pm
Great post Wildbird1.  You understand the whole picture of events.
Comment by BlueFranky on Oct 10, 2022 2:29pm
Wildbird - most excellent post! thank you!
Comment by BlueFranky on Oct 10, 2022 2:29pm
Wildbird - most excellent post! thank you!
Comment by Eoganacht on Oct 10, 2022 2:34pm
Excellent post wildbird1!
Comment by Oilminerdeluxe on Oct 10, 2022 2:48pm
Yes, indeed. Thank you, Wildbird.
Comment by Legit62 on Oct 10, 2022 3:08pm
Great post Wildbird 1 and totally agree
Comment by Tapps21 on Oct 10, 2022 3:18pm
Excellent post wild bird. Also, fantastic research Oden.  intriguing weekend reads.
Comment by Infinity on Oct 10, 2022 3:21pm
Wild bird,  I have no problem with your reasoning,  Except one,   WHY LIMIT TO ACCREDITED INVESTORS"  why not to every TLT investor or any invstor for that matter.  You can just trade the warrant at current price and you get to keep the share at HALF PRICE or close to halfr price.  Does that make any sense except for a few ACCREDITED INVESTORS
Comment by NgamiaSwede on Oct 10, 2022 3:33pm
If you let people with little money invest and they lost it all you will probebly be sued if you make sure investors have money there is a little risk of that when I was part of the PP your net income before taxes had to be 300000 CAD in the current year or had more than 1 million in cash and securiteis Investors with money is known to the risk from invest,  glta
Comment by ScienceFirst on Oct 10, 2022 4:47pm
Infinity still doesn't get it!  Gees!  This guy has no understanding of where TLT is now! At one point in time, on its way to the next crucial milestone as it matures toward commercialization, a company doesn't just need money but rather money with connections that will open additional doors.  We have many examples of that. We need key people to prepare for the next ...more  
Comment by Infinity on Oct 10, 2022 8:55pm
It is not a question of people with little money. It is a question of what is fair and within reason. Well at the end of the day, I still believe in TLD. I also know in the event of Hostile take over, who to vote for. Hopefully very soon..
Comment by robertshaw on Oct 10, 2022 9:37pm
Completely agree, fair to all of the shareholders, and trustworthy from the management is very important (not doing cheating like promised no PP needed before the end of Phase 2 , yet lied again as before... Anyway, almost all of the long shareholders only care about Sherry Ann Mcfarland 's science side..
Comment by ScienceFirst on Oct 10, 2022 9:38pm
Still at it Infinity?  Still having problems understadning that different stages require different type of investors? Money with connections is what's important from now on.  Too hard for you to understand? And an hostile takeover = no maximization of the potential. Funny that you're ready to settle for peanuts instead of true value, when you own shares in a technology that ...more  
Comment by Infinity on Oct 10, 2022 10:23pm
Hey Science first. You can pump this management all you want. Does not change a thing in terms of prudent managemement. More than Obvious that you are being FED.
Comment by Oilminerdeluxe on Oct 11, 2022 12:55am
If you are short on cash, you take money if it is offered. Now we at least have enough to start dealing with other indications. FINALLY! Not sure how the time fram of those are but hopefully GLP can start asap
Comment by Oilminerdeluxe on Oct 11, 2022 4:03am
I realize now that the 2nd PP is bettar to have than not at all. Now, go make us rich TLT. If we can get other indications going as well, that is a good thing.
Comment by ScienceFirst on Oct 11, 2022 6:17am
Still at it Infinity? instead of accusing others, being stubborn and into plot theories, just go revisit your absurd way of thinking.  And leave your lazy world and one of a dinausore that cannot even recognize where a company now stands in its growth phase and what new type of needs it has to successfully move to the next level. At this point in time, TLT doesn't your money anymore ...more  
Comment by ScienceFirst on Oct 11, 2022 6:18am
Still at it Infinity? instead of accusing others, being stubborn and into plot theories, just go revisit your absurd way of thinking.  And leave your lazy world and one of a dinausore that cannot even recognize where a company now stands in its growth phase and what new type of needs it has to successfully move to the next level. At this point in time, TLT doesn't need your money ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 63 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     


Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250